HHS Rescinds Richardson Waiver

April 9, 2025

EGWP marketplace medicaid Medicare

On Feb. 28, HHS issued a policy statement announcing changes to rulemaking processes for agencies within HHS. According to the statement, HHS is rescinding a requirement – known as the Richardson Waiver – that its agencies engage in “notice-and-comment” rulemaking for matters otherwise exempted from this process under the Administrative Procedure Act (APA). While the APA generally requires agencies to engage in notice-and-comment rulemaking before issuing regulations, there are exceptions for matters related to “agency management or personnel or to public property, loans, grants, benefits, or contracts,” or if an agency “for good cause” determines “that notice and public procedure thereon are impracticable, unnecessary, or contrary to the public interest.” 

The rescission of the Richardson Waiver means that these matters are thus exempt from notice and comment procedures, except as otherwise required by law. Of note, Medicare is separately subject to notice and comment rulemaking requirements and requirements imposed by other statutory provisions, but most programs within HHS do not have similar statutory requirements. The Social Security Act also imposes specific notice and comment requirements on Medicaid, and many ACA provisions are subject to the APA’s notice and comment requirement. HHS will need to demonstrate a good cause exemption to promulgate rulemakings without notice and comment or at least 30-days’ advance notice.

Cigna is working closely with legal counsel and trade associations to determine the impact on rulemaking processes for various agencies and programs.

legislation

CMS Releases Final 2026 MA Policy and Technical Rule; Declines to Finalize Coverage of GLP-1s

On April 4, the Centers for Medicare & Medicaid Services (CMS) finalized the 2026 MA Policy and Technical Changes rule. Of note, CMS is not finalizing certain provisions from the proposed rule, most importantly the proposal requiring coverage of anti-obesity medications (AOMs) in both Medicare and Medicaid. CMS said that it may address these proposals […]
read more >

April 9, 2025

EGWP marketplace medicaid Medicare

legislation

Budget Reconciliation Process Continues with Senate Consideration of Revised House Resolution

On April 5, the Senate voted 51-48 to pass a modified version of the House-passed budget resolution with reduced deficit reduction targets for Senate committees as compared to the House. Specific to health care, the revised Senate resolution instructs the Senate Finance Committee (SFC), which has jurisdiction over Medicaid, to propose changes that will increase […]
read more >

April 9, 2025

medicaid

legislation

2026 Final Rate Announcement for MA and Final Part D Program Instructions

On April 7, CMS released the Calendar Year (CY) 2026 MA and Part D Final Rate Announcement and the Final CY 2026 Medicare Part D Program Instructions. The Administration strongly defended its focus on fraud, waste, and abuse, while protecting beneficiaries. The final rate notice increases average payments to MA plans by 5.06% up from […]
read more >

April 9, 2025

EGWP medicaid Medicare

You may also like